Journal of the American Society of Hypertension

Journal

Publication Venue For

  • Effect of sleeve gastrectomy on hypertension.  12:e19-e25. 2018
  • Relation of urinary endothelin-1 to stress-induced pressure natriuresis in healthy adolescents.  12:34-41. 2018
  • Adherence to antihypertensive medications and associations with blood pressure among African Americans with hypertension in the Jackson Heart Study.  11:581-588.e5. 2017
  • Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States.  11:573-580. 2017
  • Involvement of vascular peroxidase 1 in angiotensin II–induced hypertrophy of H9c2 cells.  11:519-529.e1. 2017
  • Race and sex differences in ambulatory blood pressure measures among HIV+ adults.  11:420-427.e3. 2017
  • Response to letter to Editor “Lessons learned from the recent history of technologies for non-invasive estimation of aortic blood pressure using transfer functions and pulse wave analysis” by Papaioannou et al.  11:321-322. 2017
  • Clinic and ambulatory blood pressure in a population-based sample of African Americans: the Jackson Heart Study.  11:204-212.e5. 2017
  • Assessment of vascular function in low socioeconomic status preschool children: a pilot study.  11:101-109. 2017
  • Sleep, insomnia, and hypertension: current findings and future directions.  11:122-129. 2017
  • Assessment of vascular function in low socioeconomic status preschool children: A pilot study 2016
  • Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.  10:930-938.e9. 2016
  • Orthostatic changes in systolic blood pressure among SPRINT participants at baseline.  10:847-856. 2016
  • The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study.  10:857-864.e2. 2016
  • Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study.  10:702-713.e4. 2016
  • Vascular peroxidase 1 up regulation by angiotensin II attenuates nitric oxide production through increasing asymmetrical dimethylarginine in HUVECs.  10:741-751.e3. 2016
  • Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study.  10:625-632.e1. 2016
  • Hypertension and alterations in left ventricular structure and geometry in African Americans: the Jackson Heart Study.  10:550-558.e10. 2016
  • Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study.  10:578-586.e5. 2016
  • Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes, or a History of Stroke..  10 Suppl 1:e6-e7. 2016
  • HOPE-3 and SPRINT: two landmark trials with different outcomes?.  10:477-481. 2016
  • Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement.  10:493-499. 2016
  • Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: A systematic review.  10:224-234.e17. 2016
  • Obstructive sleep apnea and periodic limb movement disorder in a population of children with hypertension and/or nocturnal nondipping blood pressures.  10:101-107. 2016
  • An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial.  9:769-779. 2015
  • Tribute: John H. Laragh, MD.  9:500-501. 2015
  • Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.  9:670-679. 2015
  • Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension.  9:845-854. 2015
  • Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.  9:453-498. 2015
  • Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.  8:405-413. 2014
  • Effect of change in systolic blood pressure between clinic visits on estimated 10-year cardiovascular disease risk.  8:159-165. 2014
  • Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries.  8:898-908. 2014
  • Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.  8:808-819. 2014
  • The use of ambulatory blood pressure monitoring among Medicare beneficiaries in 2007-2010.  8:891-897. 2014
  • Dietary potassium: A key mediator of the cardiovascular response to dietary sodium chloride.  7:395-400. 2013
  • Medication adherence and stroke/TIA risk in treated hypertensives: Results from the REGARDS study.  7:363-369. 2013
  • Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: A subpopulation analysis of the TRINITY study.  6:132-141. 2012
  • Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients.  6:66-72. 2012
  • ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology,.  5:259-352. 2011
  • Adherence and persistence with taking medication to control high blood pressure..  5:56-63. 2011
  • Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: Results in racial/ethnic subgroups.  5:249-258. 2011
  • ASH position paper: dietary approaches to lower blood pressure..  4:79-89. 2010
  • Combination therapy in hypertension..  4:90-98. 2010
  • Treatment of hypertension in patients with diabetes--an update..  4:62-67. 2010
  • When and how to use self (home) and ambulatory blood pressure monitoring..  4:56-61. 2010
  • Prevalence of hypertension by duration and age at exposure to the stroke belt.  4:32-41. 2010
  • Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study.  4:22-31. 2010
  • An evaluation of the efficacy of olmesartan medoxomil in Black patients with hypertension.  3:395-402. 2009
  • Diastolic dysfunction and heart failure with preserved ejection fraction: rationale for RAAS antagonist/CCB combination therapy.  3:52-68. 2009
  • Association between endothelial biomarkers and arterial elasticity in young adults: the CARDIA Study.  2:70-79. 2008
  • ASH 2008: "Living the Vision".  2:54-55. 2008
  • Insulin's actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease.  1:414-422. 2007
  • A Good Year.  1:369-370. 2007
  • A Major Paradigm Shift.  1:162-163. 2007
  • An Open Letter to ASH Members.  1:97-98. 2007
  • JASH Inaugural Issue.  1:2. 2007
  • International Standard Serial Number (issn)

  • 1933-1711
  • Electronic International Standard Serial Number (eissn)

  • 1878-7436